1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50–70 year old AML patients
(
- Contribution to journal › Article
-
Mark
Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages : an EU COST Action cGvHD Eurograft project
(
- Contribution to journal › Letter
- 2023
-
Mark
Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST) : a study from the Transplant Complications Working Party and Nurses Group of the EBMT
(
- Contribution to journal › Article
-
Mark
Variation in hydration use after reinfusion of autologous stem cells in dimethyl sulfoxide (DMSO) : a survey of EBMTcenters on behalf of the EBMT Nurses Group
(
- Contribution to journal › Letter
-
Mark
The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell transplantation on behalf of the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Nurses Group (NG) of the EBMT
(
- Contribution to journal › Article
- 2022
-
Mark
Cancer incidence in healthy Swedish peripheral blood stem cell donors
(
- Contribution to journal › Article
-
Mark
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement : a study of the Chronic Malignancies Working Party of EBMT
(
- Contribution to journal › Article
- 2021
-
Mark
Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study
(
- Contribution to journal › Article
-
Mark
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG
(
- Contribution to journal › Article
-
Mark
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
(
- Contribution to journal › Article